UGT1A1 and fatty liver disease: We had previously shown that mice with the Gilbert’s mutation UGT1A1*28 and hyperbilirubinemia were resistant to high-fat diet-induced hepatic steatosis by inhibiting de novo lipogenesis and activation of β-oxidation (Hinds et al., 2017).